[Latest] Global Proton Therapy Market Size/Share Worth USD 2,405.6 Million by 2032 at a 12.11% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
07. März 2024 11:30 ET
|
Custom Market Insights
Austin, TX, USA, March 07, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Proton Therapy Market Size, Trends and Insights By Setup Type (Single-Room...
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board
31. Juli 2023 07:00 ET
|
BIOXYTRAN, INC.
BOSTON, MASSACHUSETTS, July 31, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral...
ArmorSource Introduces Next Generation Aire System
17. Januar 2023 09:00 ET
|
ArmorSource, LLC.
LAS VEGAS, Jan. 17, 2023 (GLOBE NEWSWIRE) -- ArmorSource has introduced its Next Generation Aire System, a full spectrum of advanced hole-free head protection solutions for military, law...
Study Investigates New Approach to Diagnosis and Treatment of Head and Neck Cancers
15. Dezember 2021 10:25 ET
|
Experimental Biology and Medicine
WASHINGTON, Dec. 15, 2021 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 246, Issue 24, December, 2021) investigates a new approach for treating...
Beazley builds large commercial property capability in US
29. Oktober 2019 07:00 ET
|
Beazley Group
New York, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Specialist insurer Beazley has appointed Matthew Westhoff as head of US large commercial property based in New York. Reporting to Beazley’s global head...
New Online Resource Tool Available for Persons with Migraine Disease to Help Address Healthcare Challenges
07. Januar 2019 05:00 ET
|
Patient Advocate Foundation
Hampton, VA, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Patient Advocate Foundation (PAF) is excited to announce the launch of its new interactive educational widget, Migraine Matters, that empowers those...
Minerva Neurosciences Names Dr. Jay Saoud as Senior Vice President, Head of Research and Development
11. September 2017 08:30 ET
|
Minerva Neurosciences, Inc.
WALTHAM, Mass., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...